GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Gain Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.25−0.01 (-0.79%)
Close on Oct 19, 2026
- Market cap
- $53.60M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Gain Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2026 | Sep 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2026 | Jun 25, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2026 | Mar 18, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 28, 2025 | Nov 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2025 | Oct 9, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2025 | Oct 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2025 | Jul 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 24, 2025 | Jun 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 24, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2025 | Apr 10, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2025 | Jan 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2025 | Jan 7, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 21, 2024 | SEC EDGAR |